ALLISON TAYLOR: Open Payments
NPI 1902518657 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 57 payments from 24 companies in 2025. Trend: 2023 $638 · 2024 $1,092 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $174 |
| Amgen Inc. | 10 | $140 |
| Travere Therapeutics, Inc. | 4 | $77 |
| Medtronic, Inc. | 1 | $53 |
| Alexion Pharmaceuticals, Inc. | 3 | $52 |
| Calliditas Therapeutics US Inc. | 2 | $43 |
| Dexcom, Inc. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $37 |
Products named: Ozempic, EVENITY, MINIMED 780G, TARPEYO, Dexcom G6 Transmitter, FARXIGA, ACTHAR, MOUNJARO.
Industry payments across ND — which companies pay providers there.
